Differential Effects of Viscum album Extract Iscador Qu on Cell Cycle Progression and Apoptosis in Cancer Cells, Harmsma, Gromme,
Ummelin, et. al., Int. J. Oncol. 2004; 25: 1521 – 1529.
Impact of Complementary Mistletoe Extract Treatment on Quality of Life
in Breast, Ovarian and Non-Small Cell Lung Cancer Patients. A Prospective, Randomized Controlled Clinical Trial, Piao, Wang, Xie,
et al. Anticancer Res. 2004; 34: 303-309.
Use of Iscador, an Extract of European Mistletoe (Viscum album) in Cancer
Treatment: Prospective Non-randomized and Randomized Matched-pair Studies Nested Within a Cohort Study, Grossarth-Maticek, Kiene,
Baumgartner & Ziegler Alt. Ther. 2001; Vol. 7 No. 3: 57-78.
Treatment of Advanced Pancreatic Cancer with Mistletoe:
Results of a Pilot Trial Friesse, et al. 1996; Anticancer Res. 16 : 915-920.
Mistletoe Extract May Be Alternative Bladder Cancer
Therapy, Elsaesser-Beile, et al. July 2005; J. Urol. 174: 176-179.
Final Results of the EORTC 18871 / DKG 80-1 Randomised
Phase III Trial: rIFN-alpha2b vs. rIGN-gamma vs. Iscador M vs. Observation After Surgery in Melanoma Patients with Either High-risk
Primary or Regional Lymph Node Metastasis, Kleeberg, Suciu, Brocker, et al., Eur. J. Cancer 2004; 40: 390-402.
Safety and Efficacy
of the Long-term Treatment of Primary Intermediate to High-risk Malignant Melanoma (UICC/AJCC stage II and III) with a Standardized
Fermented European Mistletoe Extract: Results from a Multicenter, Comparative, Epidemiological Cohort Study in Germany and Switzerland,Augustin, Bock, Hanisch, et. al., Arzeimittelforschung, 2005; 55 (1):38-49.
Anti-proliferative Effect of Iscador Against Urinary
Bladder Carcinoma, Urech, et al., Anti-Cancer Res. 2006; 26: 3049-3056.
Iscador Qu Spezial Inhibits Tube Formation, Elluru, et
al, Drug Res., 2006; 56: 461.
Palliative In-Patient Cancer Treatment in an Anthroposophic Hospital: II. Quality of Life During
and After Stationary Treatment, and Subjective Treatment Benefits, Heusser, Braun, Burtschy et al., Forsch Komplementarmed,
2006; 13: parts I & II.
Iscador in Breast Cancer (I), Leroi, Helvet Chir Acta 1977; 44.
Iscador in Breast Cancer (II),
Hellan, et. al., Krebs und Alternativ-Medizin II, 1990, Springer.
Iscador in Breast Cancer (III), Grossarth-Maticek, et. al.,Altern. Ther. Health Med., 2001; 7.
Iscador in Breast Cancer (IV), Grossarth-Maticek, et. al., Altern. Ther. Health Med., 2001;
7.
Iscador in Breast Cancer (V), Bock et. al., Drug Res. 2004; 58.
Iscador in Cancer of Different Locations, Grossarth-Maticek,
et. al., Altern. Ther. Health Med., 2001; 7: 3.
Efficacy and Safety of Long-term Complementary Treatment with Standardized European
Mistletoe Extract ( Viscum albu. L.) in Addition to the Conventional Adjuvant Oncological Therapy in Patients with Primary Non-metastatic
Breast Cancer – Results of a multicentre, comparative, epidemiological cohort study, Bock, Friedel, Hanisch et. al., Arneim-Forsch/
Drug Res. 2004; 54 No. 8: 456 – 466.
Anticancer Activity of a Lectin-rich Mistletoe Extract Injected Intratumorally into Human
Pancreatic Cancer Xenografts, Rostock, Huber, Greiner, et al., Anticancer Res 2005; 25 (3B): 1969-1975.
Reducing
Malignant Ascites Accumulation by Repeated Intraperitoneal Administrations of a Viscum album Extract, Bar-Sela, Goldberg, Beck, et
al., Anticancer Res. 2006; 26 (1B): 709-713.
Quality of Life is Improved in Breast Cancer Patients by Standardized Mistletoe
extract PS76A2 During Chemotherapy and Follow-up: a Randomised, Placebo-controlled, Double-Blind, Multicentre Clinical Trial,
Semiglazov,
Stepula, Dudov, et al., Anticancer Res. 2006; 26 (2B): 1519-1529.
Nitric-Oxide Involvement in the Anti-Tumor Effect of Mistletoe
( Viscum album L. ) Extract Iscador on Human Macrophages, Mossalayi, Alkharrat & Malvy, Arzneimittelforschung 2006;
56 (6A): 457-460.
Immunological Effector Mechanisms of a Standardized Mistletoe Extract On the Function of Human Monocytes and
Lymphocytes in vitro, ex vivo and in vivo, Heinzerling, von Baehr, Liebenthal, et al., J. Clin. Immunol. 2006; 26 (4): 347-359.
Anticancer
Activity of a Lectin-rich Mistletoe Extract Injected Intratumorally into Human Pancreatic Cancer Xenografts, Rostock, Huber,
Greiner, et al., Anticancer Res 2005; 25 (3B): 1969-1975.
Prospective Controlled Cohort Studies on Long-term Therapy of
Breast Cancer Patients with a Mistletoe Preparation (Iscador(r), Grossarth-Maticek & Ziegler, Forsch Komplementarmed 2006; 13
(5): 285-292.
Immune Modulation Using Mistletoe (Viscum album L.) Extracts Iscador, Büssing, Arzneimittelforschung 2006; 56 (6A):508-515.
Anti-proliferative Effects of Mistletoe (Viscum album L.) Extract in Urinary Bladder Carcinoma Cell Lines, Urech, Buessing,Thalmann, et al., Anticancer Res. 2006; 26 (4B): 3049-3055.
Mistletoe for Cancer? A Systematic Review of Randomised Clinical
Trials, Ernst, Schmidt & Steuer-Vogt, Int. J. Cancer 2003; 107 (2): 262-267.
Complementary Cancer Therapy: A Systematic
Review of Prospective Clinical Trials on Anthroposophic Mistletoe Extracts, Kienle & Kiene, Eur. J. Med. Res. 2007; 12 (3): 103-119
Mistletoe Therapy in Oncology, Horneber, Bueschel, Huber R, et al., Cochrane Database Syst. Rev. 2008; (2): CD003297.